Mobile

A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicentre Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release...

Mise à jour : Il y a 4 ans
Référence :

A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicentre Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release (ER)

Extrait

Critère d'inclusion

  • N32.8 - Other specified disorders of bladder ,Urinary Bladder, Overactive

Liens